J4 ›› 2015, Vol. 14 ›› Issue (2): 36-40.
Previous Articles Next Articles
Received:
Online:
Published:
Abstract:
Objective: To understand the distribution and drug resistance of pathogenic bacteria in blood culture, and provide a reference basis for clinical treatment of infectious diseases. Methods: Bact/Alert 3D system was used for blood culture, the identification of bacteria and susceptibility test were performed by VITEK- 2 Compact identification system and the Kirby-Bauer method; the distribution and drug resistance of pathogenic bacteria were analyzed statistically. Results: 391 strains of pathogenic bacteria were isolated in 4 758 specimens of blood culture, with the positive rate of 8.22%. Of 391 strains were 197 strains of Gramnegative bacillus, with the highest positive rate of E. coli(131 strains), followed by Pneumonia klebsiella bacteria(21 strains)and Onion burkholderia bacteria(10 strains), and 182 strains of Gram-positive coccus, with three highest positive rate of bacteria in order i.e. Staphylococcus epidermidis(53 strains), Staphylococcus hominis(39 strains)and Staphylococcus aureus(22 strains). The resistant rates of E. coli to ampicillin, ceftriaxone were 94.92%, 81.36%, 63.49% respectively. The resistant rates of Staphylococcus epidermidis to penicillin G, erythromycin, compound sulfamethoxazole were as high as 95.65%, 75.51%. Conclusion: A variety of pathogenic bacteria in blood culture were found, of which E. coli and Coagulase negative staphylococci were dominant and they had a high drug resistant rate to the common antibiotics. The monitoring of the drug resistance should be strengthened and antibiotics should be reasonably selected based on the result of drug sensitivity test.
Key words: blood culture, pathogenic bacteria, drug resistance
CLC Number:
R372
Li Ling, Zhang Qunzhi. The Distribution and Drug Resistance of Pathogenic Bacteria in Blood Culture[J]. J4, 2015, 14(2): 36-40.
0 / / Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: http://journal15.magtechjournal.com/Jwk_dlxyzk/EN/
http://journal15.magtechjournal.com/Jwk_dlxyzk/EN/Y2015/V14/I2/36
〔1〕Diekema D J,Pfaller M A,Jones R N,et al. Survey of bloodstream infections due to gram- negative bacilli: fre? quency of occurrence and antimicrobial susceptibility of iso? lates collected in the United States,Canada,and Latin America for the SENTRY Antimicrobial Surveillance Pro? gram〔J〕. Clin Infect Dis,1999,29(3): 595-607. 〔2〕许霞,郭述良. 肾移植术后肺部感染的研究进展〔J〕. 重 庆医学,2013,42(1):82-85. 〔3〕陈历耋,傅万海,游楚明,等. 新生儿重症监护病房早产 儿医院感染临床分析〔J〕. 中国新生儿科杂志,2013,28 (2):80-84. 〔4〕管海宁,张群智. 重症监护室非发酵菌的检出率及其耐 药性分析〔J〕. 大理学院,2011,10(12):82-84. 〔5〕仲春红. 急性白血病医院感染相关因素分析〔D〕. 济南: 山东大学,2010. 〔6〕李光辉,朱德妹,汪复,等. 2011年中国CHINET血培养 临床分离菌的分布及耐药性〔J〕. 中国感染与化疗杂志, 2013,13(4):241-247. 〔7〕吴安华,文细毛,任南,等. 医院内菌血症发病率与病原 体分析〔J〕. 中华医学杂志,2003,83(5): 46-49. 〔8〕陈庆增,罗兵,孙迎娟,等. mecA基因在金黄色葡萄球菌 中的分布及对耐药性的影响〔J〕. 中华医院感染学杂志, 2009,19(9):1028-1031. 〔9〕黄辉,周建党,聂新民,等. MecA基因在耐甲氧西林金黄 色葡萄球菌对β-内酰胺类抗生素耐药中的作用〔J〕. 中 南大学学报:医学版,2012,37(6):567-571. 〔10〕陈枫,黄永茂,曹勇,等. 产ESBLs大肠埃希菌耐药性及基 因型分析〔J〕.中国病原生物学杂志,2013,8(2):123-125. 〔11〕张永标,张扣兴,唐英春,等.产质粒介导AmpC酶和ES? BLs细菌的耐药性及β-内酰胺酶基因型研究〔J〕. 中华 微生物学和免疫学杂志,2004,24(7):77-82. 〔12〕Philippon A,Arlet G,Jacoby G A. Plasmid-determined AmpC-type beta-lactamases〔J〕. Antimicrob Agents Che? mother,2002,46(1):1-11. 〔13〕农乐关,梁桂才,覃燕玲. 临床常见革兰阳性球菌的耐 药性分析〔J〕. 检验医学与临床,2012,9(21):2688-2689. 〔14〕黄仲义,张秀珍,何礼贤,等. 万古霉素临床应用中国专 家共识(2011版)〔J〕. 中国新药与临床杂志,2011,30 (8):561-573. 〔15〕赵卫东,张群智. 2009年附属医院产超广谱β内酰胺酶 大肠埃希菌耐药性监测〔J〕. 大理学院学报,2010,9 (8):58-60. 〔16〕周东辉,张群智. 2008年大理学院附属医院肠杆菌科细 菌耐药性监测〔J〕. 大理学院学报,2009,8(12):65-68.